Hyderabad, Nov. 5 -- Nucelion Therapeutics Pvt Ltd, a wholly owned subsidiary of Bharat Biotech International Ltd, established a Contract Research Development and Manufacturing Organisation (CRDMO) focused on cell and gene therapies in Hyderabad.
The CRDMO aims to support global life science innovators with high-quality, scalable process development and manufacturing solutions for advanced therapies, indicated for cancers, autoimmune disorders, and rare genetic disorders, the vaccine maker said in a release here today.
Setting up of the wholly-owned subsidiary Nucelion Therapeutics is the part of Bharat Biotech's strategic expansion into the fast-growing field of next-generation Cell and Gene Therapy Contract Research Development and Manu...